ImmunityBio, Inc. Annual Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ImmunityBio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • ImmunityBio, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • ImmunityBio, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$40K, a 218% decline year-over-year.
  • ImmunityBio, Inc. annual Income Tax Expense (Benefit) for 2023 was -$40K, a 218% decline from 2022.
  • ImmunityBio, Inc. annual Income Tax Expense (Benefit) for 2022 was $34K, a 278% increase from 2021.
  • ImmunityBio, Inc. annual Income Tax Expense (Benefit) for 2021 was $9K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$40K -$74K -218% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $34K +$25K +278% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $9K +$1.86M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 -$1.85M -$1.74M -1658% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$105K +$398K +79.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$503K -$10K -2.03% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 -$493K +$79K +13.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-25
2016 -$572K -$271K -90% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 -$301K -$302K -30200% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $1K $0 0% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $1K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.